Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging

Abstract

Pathologically defined abnormalities in the cortical gray matter (GM) are well described in multiple sclerosis (MS) but are infrequently seen by conventional magnetic resonance imaging (MRI). We systematically evaluated 52 relapsing - remitting MS patients and 20 normal volunteers with high resolution MRI and short echo proton magnetic resonance spectroscopic imaging (MRSI). Individual tissue contributions to the spectroscopic voxels were estimated based on MRI that incorporated both CSF suppression and magnetization transfer, or double inversion images in which both CSF and GM were suppressed. Strong resonances in the 0.8 to 1.5 p.p.m. spectral region were observed in 13 MS patients. Image segmentation based on the MRI characteristics of tissues contributing to the spectroscopic voxels showed that these additional peaks originated mainly from GM. The presence of these additional peaks suggests that the normal appearance GM on MRI, is biochemically abnormal in a substantial proportion of relapsing-remitting MS patients.

Keywords

MRI MRSI multiple sclerosis lipids tissue segmentation

Get full access to this article

View all access options for this article.

References

Brownell B , Hughes T. (1962) The distribution of plaques in the cerebrum in multiple sclerosis . J Neurol Neurosurg Psychiatry 25: 315-320 .

Boggild MD , Williams R , Haq N , Hawkins CP. (1996) Cortical plaques visualized by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis . Neuroradiology 38 (Suppl 1), S10-S13 .

Bedell BJ , Narayana PA , Wolinsky JS. (1997) A dual approach for minimizing false lesion classifications on magnetic resonance images . Magn Reson Med 37: 94-102 .

Kidd D et al. (1999) Cortical lesions in multiple sclerosis . Brain 122: 17-26 .

Catalaa I et al. (1999) MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing . AJNR 20: 1613-1618 .

Bedell BJ , Narayana PA. (1998) Volumetric analysis of white matter, gray matter, and CSF using fractional volume analysis . Magn Reson Med 39: 961-969 .

Lublin FD , Reingold SC. (1997) Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology 48: 572-574 .

Kurtzke JF. (1989) The Disability Status Scale for multiple sclerosis: apologia pro DSS sua . Neurology 39: 291-302 .

Yu H , Narayana PA. (2000) Quantitative comparison of variable and constant repetition time proton spectroscopic imaging. In Eighth International Society of Magnetic Resonance in Medicine. April 1-7, 2000 Denver, CO , pp 427-427.

10.

Doyle TJ , Pathak R , Wolinsky JS , Narayana PA. (1995) Automated proton spectroscopic image processing . J Magn Reson B 106: 58-63 .

11.

Narayana PA , Johnston D , Flamig DP. (1991) In vivo proton magnetic resonance spectroscopy studies of human brain . Magn Reson Imaging 9: 303-308 .

12.

Narayana PA et al. (1989) Regional in vivo magnetic resonance spectroscopy of brain . J Magn Reson 83: 44-52 .

13.

Doyle TJ , Bedell BJ , Narayana PA. (1995) Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain . Magn Reson Med 33: 755-759 .

14.

McClean MA et al. (2000) Metabolite content in cerebral grey and white matter studied with short-echo time 1H-MRSI. In Eighth International Society of Magnetic Resonance in Medicine. April 1-7, 2000, Denver, CO , pp 1131-1131.

15.

Persciutti O , Sarchielli P , Gobbi G. (2000) 1H MRS study of occipital grey matter of multiple sclerosis patients. In Eighth International Society of Magnetic Resonance in Medicine. April 1-7, 2000, Denver, CO , pp 627-627.

16.

Narayana PA , Doyle TJ , Lai D , Wolinsky JS. (1998) Serial proteon magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis . Ann Neurol 43: 56-71 .

17.

Bakshi R et al. (1998) High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis . J Neuroimaging 8: 228-234 .

18.

Cercignani M et al. (2000) Magnetization transfer ratio and mean diffusivity of normal-appearing white and gray matter from patients with MS. In Eighth International Society of Magnetic Resonance in Medicine. April 1-7, 2000, Denver, CO , pp 232-232.